🇺🇸 PODD — Insulet Corporation

Nombre completo

Insulet Corporation

Divisa

USD

Mercado

NasdaqGS

Sector

Salud

Industria

Medical Devices

Empleados

5.400

PER ⓘ

29,00 (puede no estar actualizado)

Dividend yield

0,00% (puede no estar actualizado)

Precio objetivo analistas

167,17 USD (puede no estar actualizado)

Primera cotización

15/05/2007

Precio actualizado

hace 3 horas

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.